In a report issued on July 14, Michael Yee from Jefferies maintained a Hold rating on Amarin (AMRN – Research Report), with a price target of $1.50. The company's shares closed last Thursday at $1.33, close to its 52-week low of $1.11. According to TipRanks.com, Yee is a 1-star analyst with an average return of -2.0% and a 42.2% success rate. Yee covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Olema Pharmaceuticals, and LianBio Sponsored ADR. Currently, the analyst consensus on Amarin is a Hold with an average price target of $2.67.
https://www.tipranks.com/news/blurbs/jefferies-sticks-to-its-hold-rating-for-amarin-amrn?utm_source=advfn.com&utm_medium=referral
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Nov 2022 to Dec 2022 Click Here for more Amarin Charts.
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Dec 2021 to Dec 2022 Click Here for more Amarin Charts.